Novel Therapies for Relapsed or Refractory HER2-Positive Metastatic Breast Cancer

In this this dynamic program on the optimal treatment of patients with relapsed or refractory HER2-positive advanced breast cancer renowned breast cancer experts review and discuss key clinical data and patient case studies and look ahead at promising agents that may soon change practice.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.